ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Type 1 Diabetes Mellitus
Obesity
Diabetic Foot
Foot Ulcer
Overweight

Diabetes trials near Sevilla, AN, ESP:

Study of the Performance of the GLUCUBE System in Patients With Type 2 Diabetes

the study is to evaluate the performance of GLUCUBE in patients with diabetes type 2 and how the accuracy of the system improves as the time...

Enrolling
Diabetes Mellitus, Type 2
Device: GLUCUBE system
iGluco

Seville, Spain

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Seville, Spain and 59 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Sevilla, Spain and 78 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Sevilla, Spain and 182 other locations

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Enrolling
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

Seville, Spain and 54 other locations

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Seville, Spain and 96 other locations

The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obe...

Enrolling
Type 1 Diabetes
Overweight
Drug: Placebo
Drug: Tirzepatide

Phase 3

Lilly
Lilly

Seville, Spain and 79 other locations

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or ov...

Enrolling
Type 1 Diabetes
Overweight
Drug: Tirzepatide
Drug: Placebo

Phase 3

Lilly
Lilly

Seville, Spain and 147 other locations

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...

Active, not recruiting
Type 2 Diabetes
Overweight
Drug: Placebo
Drug: Retatrutide

Phase 3

Lilly
Lilly

Sevilla, Spain and 99 other locations

index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exer...

Active, not recruiting
Diabetes Mellitus, Type 2
Obesity
Drug: Survodutide
Drug: Placebo

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Castilleja de la Cuesta, Spain and 145 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems